EXCLUSIVE: As private citizen, Dr. Fauci received $15 million taxpayer-funded security detail
Open the Books uncovers unprecedented agreement with U.S. Marshals.
Open the Books uncovers unprecedented agreement with U.S. Marshals.
People diagnosed with metastatic breast cancer have a notably increased risk of developing heart disease.
JACC: Case Reports is inviting submissions of challenging rheumatic heart disease (RHD) cases highlighting the global burden of cardiovascular disease for a forthcoming special issue…
This cross-sectional study evaluates contemporary patterns of lipoprotein a testing among US veterans receiving care through the Veterans Health Administration.
Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, discusses her JADPRO Live workshop on how advanced practice providers can improve clinical trial representation and access.
AbstractUndifferentiated cardiac tumors represent a diagnostic dilemma that requires meticulous workup. We present the case of a 67-year-old woman with a right atrial mass that…
Heart failure with preserved ejection fraction (HFpEF) makes up ∼ 50% of HF cases of HF, and it shows increasing prevalence.1 HFpEF is characterized by…
AbstractBackgroundPrevious research has suggested that time-in-target range (TTR) for systolic blood pressure (SBP) was associated with adverse cardiovascular events, but real-world data studies re…
HFSA is pleased to welcome new members to our community dedicated to heart failure research, education, innovation, and advocacy.
Long focused on antioxidants, researchers are now exploring a new route to combat prostate cancer: pro-oxidants.
The FDA granted Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device to treat chronic systemic inflammation in patients on hemodialysis.